Analysis of Investments
Adjustment to Net Income (Loss): Mark to Market Available-for-sale Securities
Eli Lilly & Co., adjustment to net income (loss)
US$ in thousands
Based on: 10-K (filing date: 2020-02-19), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19).
Adjusted Profitability Ratios: Mark to Market Available-for-sale Securities (Summary)
Eli Lilly & Co., adjusted profitability ratios
Based on: 10-K (filing date: 2020-02-19), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19).
Profitability ratio | Description | The company |
---|---|---|
Adjusted net profit margin | An indicator of profitability, calculated as adjusted net income divided by revenue. | Eli Lilly & Co.’s adjusted net profit margin ratio improved from 2017 to 2018 and from 2018 to 2019. |
Adjusted ROE | A profitability ratio calculated as adjusted net income divided by shareholders’ equity. | Eli Lilly & Co.’s adjusted ROE improved from 2017 to 2018 and from 2018 to 2019. |
Adjusted ROA | A profitability ratio calculated as adjusted net income divided by total assets. | Eli Lilly & Co.’s adjusted ROA improved from 2017 to 2018 and from 2018 to 2019. |
Eli Lilly & Co., Profitability Ratios: Reported vs. Adjusted
Adjusted Net Profit Margin
Based on: 10-K (filing date: 2020-02-19), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19).
2019 Calculations
1 Net profit margin = 100 × Net income (loss) ÷ Revenue
= 100 × 8,318,400 ÷ 22,319,500 = 37.27%
2 Adjusted net profit margin = 100 × Adjusted net income (loss) ÷ Revenue
= 100 × 8,345,400 ÷ 22,319,500 = 37.39%
Profitability ratio | Description | The company |
---|---|---|
Adjusted net profit margin | An indicator of profitability, calculated as adjusted net income divided by revenue. | Eli Lilly & Co.’s adjusted net profit margin ratio improved from 2017 to 2018 and from 2018 to 2019. |
Adjusted Return on Equity (ROE)
Based on: 10-K (filing date: 2020-02-19), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19).
2019 Calculations
1 ROE = 100 × Net income (loss) ÷ Total Eli Lilly and Company shareholders’ equity
= 100 × 8,318,400 ÷ 2,606,900 = 319.09%
2 Adjusted ROE = 100 × Adjusted net income (loss) ÷ Total Eli Lilly and Company shareholders’ equity
= 100 × 8,345,400 ÷ 2,606,900 = 320.13%
Profitability ratio | Description | The company |
---|---|---|
Adjusted ROE | A profitability ratio calculated as adjusted net income divided by shareholders’ equity. | Eli Lilly & Co.’s adjusted ROE improved from 2017 to 2018 and from 2018 to 2019. |
Adjusted Return on Assets (ROA)
Based on: 10-K (filing date: 2020-02-19), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19).
2019 Calculations
1 ROA = 100 × Net income (loss) ÷ Total assets
= 100 × 8,318,400 ÷ 39,286,100 = 21.17%
2 Adjusted ROA = 100 × Adjusted net income (loss) ÷ Total assets
= 100 × 8,345,400 ÷ 39,286,100 = 21.24%
Profitability ratio | Description | The company |
---|---|---|
Adjusted ROA | A profitability ratio calculated as adjusted net income divided by total assets. | Eli Lilly & Co.’s adjusted ROA improved from 2017 to 2018 and from 2018 to 2019. |